This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Johnson & Johnson
Drug Names(s): JNJ63723283, JNJ 63723283
Description: JNJ63723283 is an anti-programmed death-1 (PD-1) monoclonal antibody with potential antineoplastic activity indicated for the treatment of advanced cancers.
Additional information available to subscribers only: